Phase I Biomarker Study of Dietary Grape-Derived Low Dose Resveratrol for Colon Cancer Prevention

Clinical Trial ID NCT00578396

Rank	Title	Journal	Year	PubWeight™‹?›
1	Perspectives for cancer prevention with natural compounds.	J Clin Oncol	2009	1.99
2	Wnt signaling and colon carcinogenesis: beyond APC.	J Carcinog	2011	1.44
3	Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase.	Breast Cancer Res Treat	2010	1.11
4	Resveratrol and cancer: Challenges for clinical translation.	Biochim Biophys Acta	2014	0.96
5	Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer.	Cancer Growth Metastasis	2015	0.90
6	Anticancer Molecular Mechanisms of Resveratrol.	Front Nutr	2016	0.82
7	Role of phytochemicals in colorectal cancer prevention.	World J Gastroenterol	2015	0.81
8	Regulation of colon cancer recurrence and development of therapeutic strategies.	World J Gastrointest Pathophysiol	2012	0.81
9	Effects of a grape-supplemented diet on proliferation and Wnt signaling in the colonic mucosa are greatest for those over age 50 and with high arginine consumption.	Nutr J	2015	0.76
10	EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new?	Curr Drug Targets	2010	0.76
11	Resveratrol and Malignancies.	Curr Pharmacol Rep	2015	0.75